Aepodia is a solution provider specialised in the early development of drugs and medical devices up to clinical proof-of-concept (from preclinical to Phase 2). Aepodia offers expertise and innovative approaches to its partners to optimise the clinical development programmes of products as well as the management and operational execution of clinical studies carried out in multiple countries. With offices in Belgium and France, Aepodia is a recognised partner for pharma and biotech companies.